Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Helen Rawson a Guy's, King's College, and St
Thomas's Hospitals School of Medicine and Dentistry, London SE1 8AW, b London
School of Hygiene and Tropical Medicine, London WC1E 7HT Correspondence to: N Noah norman.noah{at}lshtm.ac.uk
| |
Abstract |
|---|
|
|
|---|
Objective:
To evaluate the epidemiology and impact of mortality from chickenpox in England and Wales.
Design:
Review of death certificates from the Office for National Statistics on which codes for "chickenpox" or
"varicella" were mentioned. Further information ascertained from
certifying physician.
Participants:
Those certified as having died from
chickenpox in England and Wales, 1995-7.
Main outcome measures:
Diagnosis and age and sex
distributions of deaths from chickenpox.
Results:
On average, 25 people a year die from
chickenpox. Overall case fatality was 9.22 per 100 000 consultations
for chickenpox. Adults accounted for 81% of deaths and 19% of
consultations. Deaths were twice as common in men as in women. More of
those who died were born outside United Kingdom than expected (12%
v 4%).
Conclusions:
Chickenpox is not a mild disease. Deaths
in adults are increasing, both in number and proportion.
|
What is already known on this topic
What this study adds
|
| |
Introduction |
|---|
|
|
|---|
The age distribution of people with chickenpox and mortality from
the disease in developed countries are changing.1 In England and Wales deaths in adults have increased in
number.2 In the United States chickenpox is the leading
cause of deaths that could be prevented by vaccine.3 As
part of a larger study on the burden of chickenpox we reviewed deaths
from chickenpox in England and Wales for 1995-7.
| |
Methods |
|---|
|
|
|---|
We obtained copies of death certificates that mentioned
"chickenpox" or "varicella" (ICD-9 (international
classification of diseases, 9th revision) code 052; ICD-10 (10th
revision) code B01) for 1995-7 and data on the annual numbers of deaths
for 1985-97 from the Office for National Statistics. We sent
questionnaires to the physicians responsible for the patients to
clarify the diagnosis. Using this information we classified deaths into
those in which primary infection with varicella zoster virus was the definite or probable underlying cause of death and those in which it
could be excluded. We also reviewed confidential inquiries into
maternal deaths in the United Kingdom for 1985-96.4 The research unit of the Royal College of General Practitioners provided data on age and sex specific incidences of chickenpox.
| |
Results |
|---|
|
|
|---|
Response rates and varicella classification
We obtained 119 death certificates. Of these, we classified 71 (60%) deaths as definitely or probably due to chickenpox (for example,
chickenpox pneumonia, generalised chickenpox, etc). Of these, 58 replies from physicians confirmed 56 (97%) as definite, so we
estimated 97% (12.6) of the 13 remaining cases for which we had no
confirmation as definite (table 1). Of the 48 (40%) that we
classified as uncertain or not due to chickenpox, 19 of 36 physicians
(53%) confirmed the diagnosis on the certificate. We therefore
estimated 53% (6.3) of the 12 remaining as chickenpox. Thus, of the
original 119 deaths, we estimated that 94 (79%) were really
attributable to chickenpox (table 1). This is a lower bound value.
We had no further information for 25 cases (no reply from physician in
charge in 14 cases and notes lost in 11 cases). The overall
response rate therefore was 88% (105/119).
|
Estimating case fatality
We used general practitioners' consultation rates to estimate the
number of cases of clinical chickenpox in the population. The case
fatality was 9.22/100 000 for 1985-97. In each year, the number of
deaths certified generally closely paralleled the consultation rate for chickenpox.
|
|
| |
Discussion |
|---|
|
|
|---|
Mortality from chickenpox is not negligible. During 1995-7, 81 deaths were recorded by the Office for National Statistics. However, we received 119 certificates that mentioned chickenpox or varicella. After detailed inquiries, we estimated that at least 75 were genuine cases of chickenpox. This suggests at least 25 deaths from chickenpox annually. In 1996-7 there were seven certified deaths from whooping cough, mumps, measles, and Haemophilus influenzae type b (Hib) meningitis in England and Wales compared with 67 from chickenpox.
Specificity of diagnosis
We asked the clinician concerned to review our presumptive
diagnosis taken from the certificate. There was a good response and
excellent consistency between our assessment and theirs, especially in
those we classified as true chickenpox (consistency 97%). This
suggests high specificity. Sensitivity may have been lower because,
conversely, some deaths from chickenpox may not be correctly coded or
certificated,5 and we may have lost some. Thus our figure
of 25 deaths a year from chickenpox is probably an underestimate.
Case fatality and age
The imbalance in the number of deaths from chickenpox between
children and adults in England and Wales has been consistent since
1967. Deaths in adults have increased in number and proportion: they
accounted for 48% (88) of all deaths from chickenpox in 1967-77, 64%
(120) in 1978-85,6 and 81% (269) in 1986-97. Adults
accounted for over 81% of the confirmed deaths in our study but for
only 19% of the consultations. Chickenpox is also an important cause
of death in children aged 0-4 years because more children in that age
group catch chickenpox and because a higher proportion of them die from
the illness.
Role of vaccine
A chickenpox vaccine is available, though not yet licensed in the
United Kingdom. Our results do not on their own provide sufficient
evidence for mass vaccination. We need information not only on the
burden of disease at primary and secondary care levels, but also on the
effect of the vaccine on herpes zoster. We also need to ensure a high
enough uptake so that the disease does not shift towards the older
population and a higher mortality.
| |
Acknowledgments |
|---|
We thank the many physicians who responded to our survey, the staff of the Office for National Statistics, London, and the Royal College of General Practitioners Research Unit, Birmingham, for the supply of data, and Dr Richard Hooper for statistical advice.
Contributors: HR obtained, collated, and analysed the data and contributed to early drafts of the paper. AC contributed to the design and analysis, liaised with the certifying physicians, classified the deaths, and wrote the first draft of the paper. NN conceived and initiated the study, contributed to the interpretation of the data, and wrote the final drafts. NN will act as guarantor.
| |
Footnotes |
|---|
Funding: Pasteur Merieux MSD for studies of chickenpox morbidity and mortality.
Competing interests: NN received a grant and funding for a research assistant from Pasteur-Merieux (manufacturers of a chickenpox vaccine) and has been reimbursed in part for attending a conference.
| |
References |
|---|
|
|
|---|
| 1. | Miller E, Vurdien J, Farrington P. Shift in age in chickenpox. Lancet 1993; 341: 308-309[Medline]. |
| 2. |
Fairley CK, Miller E.
Varicella-zoster virus epidemiology a changing scene?
J Infect Dis
1996;
174(suppl 3):
314-319.
|
| 3. |
Centres for Disease Control and Prevention.
Varicella-related deaths among children United States, 1997.
MMWR Morb Mortal Wkly Rep
1998;
47:
365-368[Medline].
|
| 4. | Department of Health. Report on confidential enquiries of maternal deaths in the UK. London: HMSO and Stationery Office, 1991, 1994, 1996, 1998. |
| 5. |
Maudsley G, Williams EMI.
"Inaccuracy" in death certification where are we now?
J Pub Health
1996;
18:
59-66.
|
| 6. | Joseph CA, Noah N. Epidemiology of chickenpox in England and Wales, 1967-85. BMJ 1988; 296: 673-676. |
| 7. | Garnett GP, Cox MJ, Bundy DAP, Didier JM, St.Catharine J. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect 1993; 110: 361-372[Medline]. |
(Accepted 14 July 2001)
Read all Rapid Responses